Citation Impact
Citing Papers
Identification of a Primary Target of Thalidomide Teratogenicity
2010 StandoutScience
Oncogenic activation of the Notch1 gene by deletion of its promoter in Ikaros-deficient T-ALL
2010 StandoutNobel
Tumor Suppressor p53 Can Participate in Transcriptional Induction of the GADD45 Promoter in the Absence of Direct DNA Binding
1998
Untangling the ErbB signalling network
2001 Standout
Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
1990
Epidermal growth factor-related peptides in the pathogenesis of human breast cancer
1994
Amphiregulin as an autocrine growth factor for c-Ha-ras- and c-erbB-2-transformed human mammary epithelial cells.
1994
The DNA-damage response in human biology and disease
2009 StandoutNature
Transforming growth factors in human breast cancer
1989
EGFR Antagonists in Cancer Treatment
2008 Standout
The prognostic significance of transforming growth factors in human breast cancer
1993
Induction of Transforming Growth Factor α Expression in Mouse Mammary Epithelial Cells after Transformation with a Point-Mutated c-Ha-rasProtooncogene
1988
Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma
1993 StandoutNature
Omental and Subcutaneous Adipose Tissues of Obese Subjects Release Interleukin-6: Depot Difference and Regulation by Glucocorticoid1
1998
Stromal fibroblasts in cancer initiation and progression
2004 StandoutNature
Acute lymphoblastic leukaemia
2008
Expression of transforming growth factor α antisense mRNA inhibits the estrogen‐induced production of TGFα and estrogen‐induced proliferation of estrogen‐responsive human breast cancer cells
1993
Increased oxidative stress in obesity and its impact on metabolic syndrome
2004 Standout
The Physiology Of Transforming Growth Factor-α
1992
Growth factors and oncogenes in breast cancer
1990
Epidermal growth factor-related peptides and their receptors in human malignancies
1995 Standout
Cardiac Failure and Dysrhythmias 6–19 Years After Anthracycline Therapy: A Series of 15 Patients
1995
The Spectrum of Dilated Cardiomyopathy: The Johns Hopkins Experience with 1,278 Patients
1999
Cross-talk between Epidermal Growth Factor Receptor and c-Met Signal Pathways in Transformed Cells
2000
Cytogenetic and pathologic aspects of Ewing's sarcoma and neuroectodermal tumors
1992
Phosphorylation of middle T by pp60c-src: A switch for binding of phosphatidylinositol 3-kinase and optimal tumorigenesis
1989
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
WHO-EORTC classification for cutaneous lymphomas
2005 Standout
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance
2003 Standout
Heparin inhibition of autonomous growth implicates amphiregulin as an autocrine growth factor for normal human mammary epithelial cells
1992
Contribution of molecular genetic data to the classification of sarcomas
2000
Inflammation and insulin resistance
2006 Standout
Regulation of Transforming Growth Factor α and Transforming Growth Factor β Messenger Ribonucleic Acid Abundance in T-47D, Human Breast Cancer Cells
1989
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
Epidermal growth factor receptor (EGFR) as a target in cancer therapy: understanding the role of receptor expression and other molecular determinants that could influence the response to anti-EGFR drugs
2003
Estrogen induction of TGF-α is mediated by an estrogen response element composed of two imperfect palindromes
1996
Expression of the Transforming Growth Factor-α/Epidermal Growth Factor Receptor Pathway in Normal Human Breast Epithelial Cells
1990
The golden age: gold nanoparticles for biomedicine
2011 Standout
Interaction between estradiol and growth factors in the regulation of specific gene expression in MCF-7 human breast cancer cells
1997
The microenvironment of the tumour–host interface
2001 StandoutNature
Regulation by Estrogen through the 5′-Flanking Region of the Transforming Growth Factor α Gene
1991
Transforming growth factor-α messenger RNA localization in the developing adult rat and human mammary gland by in situ hybridization
1990
Visualizing Sexual Dimorphism in the Brain
2004 StandoutNobel
Estrogen Receptors in Human Nontarget Tissues: Biological and Clinical Implications*
1995
Cutaneous Manifestations of Lymphoma: A Clinical Guide Based on the WHO Classification
2001
Transformation of an established mouse mammary epithelial cell line following transfection with a human transforming growth factor alpha cDNA
1989
Chlovalicin, a New Cytocidal Antibiotic Produced by Sporothrix sp. FO-4649. I Taxonomy, Fermentation, Isolation and Biological Activities.
1996 StandoutNobel
Initial congestive heart failure, six to ten years after doxorubicin chemotherapy for childhood cancer
1990
Regulation of the mevalonate pathway
1990 StandoutNature
Epidermal growth factor in breast cancer
1990
Elevated C-Reactive Protein Levels in Overweight and Obese Adults
1999 Standout
EGF and TGF‐α, the ligands of hyperproduced EGFR in human esophageal carcinoma cells, act as autocrine growth factors
1990
Oncogenes and signal transduction
1991 Standout
Inflammation and cancer: back to Virchow?
2001 Standout
Classification of anticancer drugs—a new system based on therapeutic targets
2003
Expression of transforming growth factor α, amphiregulin and cripto-1 in human breast carcinomas
1994
The EGF Receptor System as a Target for Antitumor Therapy
1991
Clonal selection and learning in the antibody system
1996 StandoutNature
Molecular basis of agonism and antagonism in the oestrogen receptor
1997 StandoutNature
Down-regulation of transforming growth factor-α by tamoxifen in human breast cancer
1993
Cloning and characterization of the Ewing's sarcoma and peripheral neuroepithelioma t(11;22) translocation breakpoints
1992
4. The role of the epidermal growth factor receptor and the c-erbB-2 protein in breast cancer
1990
Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours
1992 StandoutNature
Somatic cell genetics and the study of cholesterol metabolism
1988
5-Fluorouracil: mechanisms of action and clinical strategies
2003 Standout
Production and Actions of Estrogens
2002 Standout
A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis
1995 Standout
Development and application of high‐performance affinity beads: Toward chemical biology and drug discovery
2009
Late Cardiac Effects of Doxorubicin Therapy for Acute Lymphoblastic Leukemia in Childhood
1991 Standout
Cellular and Molecular Mechanisms of B Lymphocyte Tolerance
1992
TGFα deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice
1993 StandoutNobel
Transforming growth factor-α in normal and neoplastic human endocrine tissues
1992
Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the ‘cutaneous variant’1
2004
Obesity is associated with macrophage accumulation in adipose tissue
2003 Standout
Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease
1996 Standout
Gold nanoparticles in biomedical applications: recent advances and perspectives
2011 Standout
The Ewing Family of Tumors -- A Subgroup of Small-Round-Cell Tumors Defined by Specific Chimeric Transcripts
1994 Standout
Doxorubicin-Induced Cardiomyopathy
1998 Standout
A Conditional Mouse Model of Synovial Sarcoma: Insights into a Myogenic Origin
2007 StandoutNobel
Mechanisms of normal and malignant breast epithelial growth regulation
1989
Autonomous proliferation of colon cancer cells that coexpress transforming growth factor α and its receptor
1992
Chromosomes in Ewing's sarcoma. I. An evaluation of 85 cases and remarkable consistency of t(11;22)(q24;q12)
1988
Tamoxifen−Poly(ethylene glycol)−Thiol Gold Nanoparticle Conjugates: Enhanced Potency and Selective Delivery for Breast Cancer Treatment
2009
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
1999 StandoutScience
Eicosanoids in regulation of arterial smooth muscle cell phenotype, proliferative capacity, and cholesterol metabolism.
1989
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
2003 Standout
SH2 domains recognize specific phosphopeptide sequences
1993 Standout
Underlying Causes and Long-Term Survival in Patients with Initially Unexplained Cardiomyopathy
2000 Standout
Molecular analysis of the cytokine network involved in cachexia in colon 26 adenocarcinoma-bearing mice.
1995
The Caenorhabditis elegans gene lin-1 encodes an ETS-domain protein and defines a branch of the vulval induction pathway.
1995 StandoutNobel
Probucol Protects Against Adriamycin Cardiomyopathy Without Interfering With Its Antitumor Effect
1995
Increase in membrane cholesterol: A possible trigger for degradation of HMG CoA reductase and crystalloid endoplasmic reticulum in UT-1 cells
1984 StandoutNobel
Estrogen regulates metabolism of Alzheimer amyloid beta precursor protein.
1994
Estrogens, antiestrogens and cell proliferation
1989
The role of ras gene expression and transforming growth factor α production in the etiology and progression of rodent and human breast cancer
1991
Autonomous growth of androgen-independent human prostatic carcinoma cells: role of transforming growth factor alpha.
1991
TGF alpha and TGF beta expression in mammary carcinoma
1993
Growth Factors and Cancer
1991 StandoutScience
Up-regulation of transforming growth factor alpha expression by transforming growth factor beta 1, epidermal growth factor, and N,N-dimethylformamide in human colon carcinoma cells.
1993
G 1 Events and Regulation of Cell Proliferation
1989 StandoutScience
Isoprene synthesis in isolated embryonic Drosophila cells. I. Sterol-deficient eukaryotic cells.
1983
Mammary tumor suppression by transforming growth factor beta 1 transgene expression.
1995
Estrogen Receptor Function as Revealed by Knockout Studies: Neuroendocrine and Behavioral Aspects
1997
Expression and functional properties of transforming growth factor alpha and epidermal growth factor during mouse mammary gland ductal morphogenesis.
1991
The Caenorhabditis elegans IMPAS gene, imp-2, is essential for development and is functionally distinct from related presenilins
2004 StandoutNobel
Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential.
1990
Overexpression of TGFα in transgenic mice: Induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast
1990
Autocrine transforming growth factor-alpha is associated with progression of transformed properties in human colon cancer cells.
1993
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
2001 Standout
Transforming growth factor alpha dramatically enhances oncogene-induced carcinogenesis in transgenic mouse pancreas and liver.
1993
Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein Kinase
1995 StandoutScience
Transforming Growth Factor Alpha Dramatically Enhances Oncogene-Induced Carcinogenesis in Transgenic Mouse Pancreas and Liver
1993
Conserved Structures and Diversity of Functions of RNA-Binding Proteins
1994 StandoutScience
Epidermal growth factor gene expression in human breast cancer biopsy samples: relationship to estrogen and progesterone receptor gene expression.
1990
Epidermal growth factor and transforming growth factor-alpha: differential intracellular routing and processing of ligand-receptor complexes.
1991
The Amphiregulin Gene Encodes a Novel Epidermal Growth Factor-Related Protein with Tumor-Inhibitory Activity
1990
Biology of Cachexia
1997
The two faces of transforming growth factor β in carcinogenesis
2003 Standout
Transforming growth factor-alpha acts as an autocrine growth factor in ovarian carcinoma cell lines.
1992
Works of Carl E. Freter being referenced
Intravascular Large Cell Lymphoma Coexisting Within Hemangiomas of the Skin
1997
Expression of Transforming Growth Factor α and its Messenger Ribonucleic Acid in Human Breast Cancer: Its Regulation by Estrogen and its Possible Functional Significance
1988
Translocation t(11;22) in esthesioneuroblastoma
1987
Alterations in Phosphoinositide Metabolism Associated with 17β-Estradiol and Growth Factor Treatment of MCF-7 Breast Cancer Cells
1988
Dexamethasone and Suramin Inhibit Cell Proliferation and Interleukin-6-Mediated Immunoglobulin Secretion in Human Lymphoid and Multiple Myeloma Cell Lines
1995
Brief-Duration High-Intensity Chemotherapy for Patients With Small Noncleaved–Cell Lymphoma or FAB L3 Acute Lymphocytic Leukemia: Results of Cancer and Leukemia Group B Study 9251
2001
Effect of membrane sterol content on the susceptibility of phospholipids to phospholipase A2.
1983
Anti-IgM-mediated growth inhibition of a human B lymphoma cell line is independent of phosphatidylinositol turnover and protein kinase C activation and involves tyrosine phosphorylation.
1991
Doxorubicin cardiac toxicity manifesting seven years after treatment. Case report and review
1986
Alemtuzumab in Previously Treated Chronic Lymphocytic Leukemia Patients Who Also Had Received Fludarabine
2002
Suramin interferes with interleukin-6 receptor binding in vitro and inhibits colon-26-mediated experimental cancer cachexia in vivo.
1993
Membrane phospholipid alterations in response to sterol depletion of LM cells. Metabolic studies.
1979